BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36309561)

  • 1. UTX loss alters therapeutic responses in KMT2A-rearranged acute myeloid leukemia.
    Zhou X; Zhang P; Aryal S; Zhang L; Lu R
    Leukemia; 2023 Jan; 37(1):226-230. PubMed ID: 36309561
    [No Abstract]   [Full Text] [Related]  

  • 2. KMT2A-rearranged infantile acute myeloid leukemia masquerading as juvenile myelomonocytic leukemia.
    Kanayama T; Imamura T; Kawabe Y; Osone S; Tahara J; Iwasaki F; Miyagawa N; Goto H; Imashuku S; Hosoi H
    Int J Hematol; 2018 Dec; 108(6):665-669. PubMed ID: 30143999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid lineage switch in
    Bataller A; Abuasab T; McCall D; Wang W; Cuglievan B; Issa GC; Jabbour E; Short N; DiNardo CD; Tang G; Garcia-Manero G; Kantarjian HM; Sasaki K
    Haematologica; 2024 Jan; 109(1):293-297. PubMed ID: 37646654
    [No Abstract]   [Full Text] [Related]  

  • 4. Myeloid sarcoma concurrent with de novo KMT2A gene-rearranged infantile acute lymphoblastic leukemia.
    Abe H; Hamada S; Sakiyama H; Oshiro T; Kato M; Yagi T; Matsuda T; Higa T; Hyakuna N; Nakanishi K
    Pediatr Blood Cancer; 2022 Apr; 69(4):e29573. PubMed ID: 35044058
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemia.
    Vetro C; Haferlach T; Meggendorfer M; Stengel A; Jeromin S; Kern W; Haferlach C
    Cancer Genet; 2020 Jan; 240():15-22. PubMed ID: 31698332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital acute myeloid leukaemia with KMT2A rearrangement.
    Wan Ariffin E; Jones H; Bhatnagar N
    Br J Haematol; 2018 Jul; 182(2):169. PubMed ID: 29797490
    [No Abstract]   [Full Text] [Related]  

  • 7. Gemtuzumab ozogamicin in (KMT2A)-rearranged adult acute myeloid leukaemia (AML) in the UK Medical Research Council AML15 and AML16 trials.
    Dillon R; Hills RK; Burnett AK; Russell NH
    Br J Haematol; 2022 Mar; 196(5):e50-e52. PubMed ID: 34799856
    [No Abstract]   [Full Text] [Related]  

  • 8. The stem cell-specific long noncoding RNA HOXA10-AS in the pathogenesis of KMT2A-rearranged leukemia.
    Al-Kershi S; Bhayadia R; Ng M; Verboon L; Emmrich S; Gack L; Schwarzer A; Strowig T; Heckl D; Klusmann JH
    Blood Adv; 2019 Dec; 3(24):4252-4263. PubMed ID: 31867596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancer-activated RET confers protection against oxidative stress to KMT2A-rearranged acute myeloid leukemia.
    Frett B; Stephens KE; Koss B; Melnyk S; Farrar J; Saha D; Roy Choudhury S
    Cancer Sci; 2024 Mar; 115(3):963-973. PubMed ID: 38226414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric
    Pollard JA; Guest E; Alonzo TA; Gerbing RB; Loken MR; Brodersen LE; Kolb EA; Aplenc R; Meshinchi S; Raimondi SC; Hirsch B; Gamis AS
    J Clin Oncol; 2021 Oct; 39(28):3149-3160. PubMed ID: 34048275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed-phenotype acute leukemia with t(4;11)(q21;q23)
    Liu H
    Blood; 2019 Mar; 133(11):1265. PubMed ID: 30872272
    [No Abstract]   [Full Text] [Related]  

  • 12. A new breakpoint fusion gene involving KMT2A::EDC4 rearrangement in de novo acute myeloid leukemia.
    Hu DY; Wang M; Shen K; Pan JL; Guo YS; Zhang ZB; Zhang FH; Yin J; Chen SN
    Int J Lab Hematol; 2023 Aug; 45(4):596-598. PubMed ID: 36811287
    [No Abstract]   [Full Text] [Related]  

  • 13. The KMT2A rearrangement is an early event prior to KMT2A-PTD in AML patients with both molecular aberrations.
    Huang J; Zhu Y; Li J; Yang G; Zhang S
    Ann Hematol; 2023 Feb; 102(2):495-497. PubMed ID: 36525029
    [No Abstract]   [Full Text] [Related]  

  • 14. The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia.
    Balgobind BV; Zwaan CM; Pieters R; Van den Heuvel-Eibrink MM
    Leukemia; 2011 Aug; 25(8):1239-48. PubMed ID: 21566656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell transplantation for pediatric acute myeloid leukemia patients with KMT2A rearrangement; A nationwide retrospective analysis in Japan.
    Miyamura T; Kudo K; Tabuchi K; Ishida H; Tomizawa D; Adachi S; Goto H; Yoshida N; Inoue M; Koh K; Sasahara Y; Fujita N; Kakuda H; Noguchi M; Hiwatari M; Hashii Y; Kato K; Atsuta Y; Okamoto Y
    Leuk Res; 2019 Dec; 87():106263. PubMed ID: 31707119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel KMT2A::DCP1B rearrangement in chronic neutrophilic leukemia.
    Yang L; Yang X; Zhuang Y; Wang J; Chen X; Hu W; Shan D; Rong R; Zhou X; Xiao S
    Int J Lab Hematol; 2024 Feb; 46(1):165-168. PubMed ID: 37712389
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in
    Fournier E; Inchiappa L; Delattre C; Pignon JM; Danicourt F; Bemba M; Roche-Lestienne C; Daudignon A; Decool G; Roumier C; Dumezy F; Fournier L; Grardel N; Preudhomme C; Duployez N
    Leuk Lymphoma; 2019 Jul; 60(7):1827-1830. PubMed ID: 30616415
    [No Abstract]   [Full Text] [Related]  

  • 18. PAX5 alterations in an infant case of KMT2A-rearranged leukemia with lineage switch.
    Nakajima K; Kubota H; Kato I; Isobe K; Ueno H; Kozuki K; Tanaka K; Kawabata N; Mikami T; Tamefusa K; Nishiuchi R; Saida S; Umeda K; Hiramatsu H; Adachi S; Takita J
    Cancer Sci; 2022 Jul; 113(7):2472-2476. PubMed ID: 35467057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A distinct core regulatory module enforces oncogene expression in KMT2A-rearranged leukemia.
    Harada T; Heshmati Y; Kalfon J; Perez MW; Xavier Ferrucio J; Ewers J; Hubbell Engler B; Kossenkov A; Ellegast JM; Yi JS; Bowker A; Zhu Q; Eagle K; Liu T; Kai Y; Dempster JM; Kugener G; Wickramasinghe J; Herbert ZT; Li CH; Vrabič Koren J; Weinstock DM; Paralkar VR; Nabet B; Lin CY; Dharia NV; Stegmaier K; Orkin SH; Pimkin M
    Genes Dev; 2022 Mar; 36(5-6):368-389. PubMed ID: 35301220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/
    Bill M; Mrózek K; Kohlschmidt J; Eisfeld AK; Walker CJ; Nicolet D; Papaioannou D; Blachly JS; Orwick S; Carroll AJ; Kolitz JE; Powell BL; Stone RM; de la Chapelle A; Byrd JC; Bloomfield CD
    Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26340-26346. PubMed ID: 33020282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.